Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 137

1.

A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection.

Akahata W, Yang ZY, Andersen H, Sun S, Holdaway HA, Kong WP, Lewis MG, Higgs S, Rossmann MG, Rao S, Nabel GJ.

Nat Med. 2010 Mar;16(3):334-8. doi: 10.1038/nm.2105. Epub 2010 Jan 28.

PMID:
20111039
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.

Kam YW, Lum FM, Teo TH, Lee WW, Simarmata D, Harjanto S, Chua CL, Chan YF, Wee JK, Chow A, Lin RT, Leo YS, Le Grand R, Sam IC, Tong JC, Roques P, Wiesmüller KH, Rénia L, Rötzschke O, Ng LF.

EMBO Mol Med. 2012 Apr;4(4):330-43. doi: 10.1002/emmm.201200213. Epub 2012 Mar 5.

PMID:
22389221
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infection.

García-Arriaza J, Cepeda V, Hallengärd D, Sorzano CÓ, Kümmerer BM, Liljeström P, Esteban M.

J Virol. 2014 Mar;88(6):3527-47. doi: 10.1128/JVI.03418-13. Epub 2014 Jan 8.

PMID:
24403588
[PubMed - indexed for MEDLINE]
4.

Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits.

Metz SW, Martina BE, van den Doel P, Geertsema C, Osterhaus AD, Vlak JM, Pijlman GP.

Vaccine. 2013 Dec 9;31(51):6092-6. doi: 10.1016/j.vaccine.2013.09.045. Epub 2013 Oct 5.

PMID:
24099875
[PubMed - indexed for MEDLINE]
5.

A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease.

Selvarajah S, Sexton NR, Kahle KM, Fong RH, Mattia KA, Gardner J, Lu K, Liss NM, Salvador B, Tucker DF, Barnes T, Mabila M, Zhou X, Rossini G, Rucker JB, Sanders DA, Suhrbier A, Sambri V, Michault A, Muench MO, Doranz BJ, Simmons G.

PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2423. doi: 10.1371/journal.pntd.0002423. eCollection 2013.

PMID:
24069479
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus.

Brandler S, Ruffié C, Combredet C, Brault JB, Najburg V, Prevost MC, Habel A, Tauber E, Desprès P, Tangy F.

Vaccine. 2013 Aug 12;31(36):3718-25. doi: 10.1016/j.vaccine.2013.05.086. Epub 2013 Jun 4.

PMID:
23742993
[PubMed - indexed for MEDLINE]
7.

Effective chikungunya virus-like particle vaccine produced in insect cells.

Metz SW, Gardner J, Geertsema C, Le TT, Goh L, Vlak JM, Suhrbier A, Pijlman GP.

PLoS Negl Trop Dis. 2013;7(3):e2124. doi: 10.1371/journal.pntd.0002124. Epub 2013 Mar 14.

PMID:
23516657
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Chattopadhyay A, Wang E, Seymour R, Weaver SC, Rose JK.

J Virol. 2013 Jan;87(1):395-402. doi: 10.1128/JVI.01860-12. Epub 2012 Oct 17.

PMID:
23077320
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primates.

Mallilankaraman K, Shedlock DJ, Bao H, Kawalekar OU, Fagone P, Ramanathan AA, Ferraro B, Stabenow J, Vijayachari P, Sundaram SG, Muruganandam N, Sarangan G, Srikanth P, Khan AS, Lewis MG, Kim JJ, Sardesai NY, Muthumani K, Weiner DB.

PLoS Negl Trop Dis. 2011 Jan 11;5(1):e928. doi: 10.1371/journal.pntd.0000928.

PMID:
21264351
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.

Kumar M, Sudeep AB, Arankalle VA.

Vaccine. 2012 Sep 21;30(43):6142-9. doi: 10.1016/j.vaccine.2012.07.072. Epub 2012 Aug 8.

PMID:
22884660
[PubMed - indexed for MEDLINE]
11.

Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.

Hallengärd D, Kakoulidou M, Lulla A, Kümmerer BM, Johansson DX, Mutso M, Lulla V, Fazakerley JK, Roques P, Le Grand R, Merits A, Liljeström P.

J Virol. 2014 Mar;88(5):2858-66. doi: 10.1128/JVI.03453-13. Epub 2013 Dec 26.

PMID:
24371047
[PubMed - indexed for MEDLINE]
12.

Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.

Chu H, Das SC, Fuchs JF, Suresh M, Weaver SC, Stinchcomb DT, Partidos CD, Osorio JE.

Vaccine. 2013 Jul 18;31(33):3353-60. doi: 10.1016/j.vaccine.2013.05.059. Epub 2013 May 29.

PMID:
23727003
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

DNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in mice.

Tretyakova I, Hearn J, Wang E, Weaver S, Pushko P.

J Infect Dis. 2014 Jun 15;209(12):1882-90. doi: 10.1093/infdis/jiu114. Epub 2014 Feb 28.

PMID:
24585894
[PubMed - indexed for MEDLINE]
14.

Chimeric alphavirus vaccine candidates for chikungunya.

Wang E, Volkova E, Adams AP, Forrester N, Xiao SY, Frolov I, Weaver SC.

Vaccine. 2008 Sep 15;26(39):5030-9. doi: 10.1016/j.vaccine.2008.07.054. Epub 2008 Aug 8.

PMID:
18692107
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency.

Warter L, Lee CY, Thiagarajan R, Grandadam M, Lebecque S, Lin RT, Bertin-Maghit S, Ng LF, Abastado JP, Desprès P, Wang CI, Nardin A.

J Immunol. 2011 Mar 1;186(5):3258-64. doi: 10.4049/jimmunol.1003139. Epub 2011 Jan 28.

PMID:
21278338
[PubMed - indexed for MEDLINE]
Free Article
16.

A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis.

Wang D, Suhrbier A, Penn-Nicholson A, Woraratanadharm J, Gardner J, Luo M, Le TT, Anraku I, Sakalian M, Einfeld D, Dong JY.

Vaccine. 2011 Mar 24;29(15):2803-9. doi: 10.1016/j.vaccine.2011.01.108. Epub 2011 Feb 12.

PMID:
21320541
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling.

Partidos CD, Weger J, Brewoo J, Seymour R, Borland EM, Ledermann JP, Powers AM, Weaver SC, Stinchcomb DT, Osorio JE.

Vaccine. 2011 Apr 5;29(16):3067-73. doi: 10.1016/j.vaccine.2011.01.076. Epub 2011 Feb 5.

PMID:
21300099
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine.

Bao H, Ramanathan AA, Kawalakar O, Sundaram SG, Tingey C, Bian CB, Muruganandam N, Vijayachari P, Sardesai NY, Weiner DB, Ugen KE, Muthumani K.

Viral Immunol. 2013 Feb;26(1):75-83. doi: 10.1089/vim.2012.0061.

PMID:
23409931
[PubMed - indexed for MEDLINE]
19.

Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.

Roy CJ, Adams AP, Wang E, Plante K, Gorchakov R, Seymour RL, Vinet-Oliphant H, Weaver SC.

J Infect Dis. 2014 Jun 15;209(12):1891-9. doi: 10.1093/infdis/jiu014. Epub 2014 Jan 7.

PMID:
24403555
[PubMed - indexed for MEDLINE]
20.

Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine.

Partidos CD, Paykel J, Weger J, Borland EM, Powers AM, Seymour R, Weaver SC, Stinchcomb DT, Osorio JE.

Vaccine. 2012 Jun 29;30(31):4638-43. doi: 10.1016/j.vaccine.2012.04.099. Epub 2012 May 11.

PMID:
22583812
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk